Results 141 to 150 of about 24,759 (261)

Beta Thalassemia and Chronic Myeloid Leukemia: Dual Diagnosis Under the Microscope

open access: yes
International Journal of Laboratory Hematology, EarlyView.
Paige Muir   +3 more
wiley   +1 more source

Functional validation of a modified platelet desialylation test for immune and hereditary thrombocytopenias

open access: yesTransfusion Medicine, EarlyView.
Abstract Background Thrombocytopenia arises from heterogeneous inherited and acquired disorders, and identifying the underlying platelet clearance mechanisms remains challenging. Platelet desialylation, characterised by loss of sialic acid and consequent exposure of terminal β‐galactose residues recognised by the Ashwell–Morell receptor, represents an ...
Karen Nogueira Chinoca Ziza   +14 more
wiley   +1 more source

Tracing the in vivo behavior of nucleated cultured red blood cells generated from hematopoietic stem and progenitor cells. [PDF]

open access: yesStem Cell Res Ther
Xu L   +10 more
europepmc   +1 more source

Acquired Elliptocytosis With Hemolytic Anemia in Myelodysplastic Neoplasm With del(20q)

open access: yes
International Journal of Laboratory Hematology, EarlyView.
Nina Sicard   +4 more
wiley   +1 more source

Simple image analysis for reliability control of column agglutination test in pretransfusion testing

open access: yesTransfusion Medicine, EarlyView.
Abstract Objectives A novel meniscus‐based analysis provides a rapid method to identify analytical errors related to unrecognised pipetting errors. Background The indirect antihuman globulin test (IAT) is part of pretransfusion testing, enabling detection of erythrocyte alloantibodies.
Martin Töffner Pedersen   +5 more
wiley   +1 more source

Clinical implications of imlifidase interference in antibody screening and transfusion management

open access: yesTransfusion, EarlyView.
Abstract Background Imlifidase has received conditional approval from the EMA for desensitizing deceased donor kidney transplant recipients. It works by cleaving IgG into F(ab′)2 and Fc fragments, thereby reducing the risk of antibody‐mediated rejection. However, its impact on diagnostic assays remains understudied. Case Report We present the case of a
Zgjim Osmani   +2 more
wiley   +1 more source

Monocyte Monolayer Assay as a Tool in the Early Assessment of the Severity of the Alloantibodies in Patients with Hemolytic Disease of the Fetus and Newborn. [PDF]

open access: yesTransfus Med Hemother
Santoro D   +10 more
europepmc   +1 more source

Fucosylation limits ADCC in clinically used anti‐RhD monoclonal antibodies

open access: yesTransfusion, EarlyView.
Abstract Background Haemolytic disease of the fetus and newborn (HDFN) is caused by maternal alloantibodies, often targeting the D antigen on fetal red blood cells. Maternal immunization is preventable with timely administration of anti‐D polyclonal antibodies (pAbs).
Gabriela Koike   +33 more
wiley   +1 more source

Home - About - Disclaimer - Privacy